J. B. Chemicals & Pharmaceuticals Limited Stock price NSE India S.E.

Equities

JBCHEPHARM

INE572A01036

Pharmaceuticals

Delayed NSE India S.E. 08:02:00 2024-03-28 am EDT 5-day change 1st Jan Change
1,650 INR +0.46% Intraday chart for J. B. Chemicals & Pharmaceuticals Limited +1.93% +1.58%
Sales 2024 * 35.04B 420M Sales 2025 * 40.65B 488M Capitalization 256B 3.07B
Net income 2024 * 5.67B 68.08M Net income 2025 * 7.08B 84.95M EV / Sales 2024 * 7.35 x
Net Debt 2024 * 1.62B 19.45M Net cash position 2025 * 4.3B 51.55M EV / Sales 2025 * 6.19 x
P/E ratio 2024 *
42.4 x
P/E ratio 2025 *
33.9 x
Employees 5,095
Yield 2024 *
0.67%
Yield 2025 *
0.79%
Free-Float 45.81%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on J. B. Chemicals & Pharmaceuticals Limited

1 day+0.46%
1 week+1.93%
Current month+5.67%
1 month+3.14%
3 months+3.11%
6 months+17.14%
Current year+1.58%
More quotes
1 week
1 557.05
Extreme 1557.05
1 694.70
1 month
1 509.05
Extreme 1509.05
1 694.70
Current year
1 480.00
Extreme 1480
1 940.00
1 year
875.00
Extreme 875
1 940.00
3 years
604.00
Extreme 604
1 940.00
5 years
155.98
Extreme 155.975
1 940.00
10 years
61.90
Extreme 61.9
1 940.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 20-10-04
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 58 20-08-30
Director/Board Member 41 Nov. 06
Director/Board Member 48 21-02-09
More insiders
Date Price Change Volume
24-03-28 1,650 +0.46% 147,335
24-03-27 1,643 +1.66% 239,628
24-03-26 1,616 -0.54% 165,067
24-03-22 1,625 +0.34% 75,585
24-03-21 1,619 +2.02% 169,047

Delayed Quote NSE India S.E., March 28, 2024 at 08:02 am EDT

More quotes
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
1,649 INR
Average target price
1,887 INR
Spread / Average Target
+14.38%
Consensus
  1. Stock
  2. Equities
  3. Stock J. B. Chemicals & Pharmaceuticals Limited
  4. Stock J. B. Chemicals & Pharmaceuticals Limited - NSE India S.E.